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Abstract: Egg yolk contains bioactive components that improve plasma inflammatory
markers and HDL profiles in metabolic syndrome (MetS) under carbohydrate restriction.
We further sought to determine whether egg yolk intake affects peripheral blood
mononuclear cell (PBMC) inflammation and cholesterol homeostasis in MetS, as HDL and
its associated lipid transporter ATP-binding cassette transporter A1 (ABCA1) reduce the
inflammatory potential of leukocytes through modulation of cellular cholesterol content
and distribution. Thirty-seven men and women classified with MetS consumed a moderate
carbohydrate-restricted diet (25%–30% of energy) for 12 weeks, in addition to consuming
either three whole eggs per day (EGG) or the equivalent amount of yolk-free egg substitute
(SUB). Interestingly, lipopolysaccharide-induced PBMC IL-1β and TNFα secretion
increased from baseline to week 12 in the SUB group only, despite increases in PBMC
toll-like receptor 4 (TLR4) mRNA expression in the EGG group. Compared to baseline,
ABCA1 and 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase mRNA expression
increased by week 12 in the EGG group only, whereas changes in PBMC total cholesterol
positively correlated with changes in lipid raft content. Together, these findings suggest
that intake of whole eggs during carbohydrate restriction alters PBMC inflammation and
cholesterol homeostasis in MetS.
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1. Introduction
Chronic, low-grade inflammation is commonly associated with obesity-related metabolic diseases, and
is often indicative of organ stress and insufficient resolution of inflammatory immune responses [1–3].
Elevated levels of plasma inflammatory markers have been reported in cardiovascular disease (CVD),
type 2 diabetes mellitus (T2DM), and metabolic syndrome (MetS) [4,5]. These cytokines, chemokines,
adhesion molecules, and acute phase proteins may be derived from metabolically stressed adipose
tissue, liver, and skeletal muscle, in addition to activated leukocytes [1–3].
Recent studies have specifically focused on the role of leukocytes in contributing to metabolic
disease progression [6,7], as well as how obesity can affect basic leukocyte properties and function in
conferring immunity [8]. Multiple studies have demonstrated that factors related to obesity increase the
basal inflammatory profile of lymphocytes [9,10], in addition to promoting greater pro-inflammatory
responses upon stimulation and activation [11,12]. The consequences of these actions can include
altered monocyte and lymphocyte migration and adhesion patterns, impaired immunity, prolonged
systemic inflammation, and greater difficulty in resolving acute inflammatory responses. These
changes have further been linked to greater progression of atherosclerosis, arterial dysfunction, adipose
tissue inflammation and dysfunction, and insulin resistance [7,11,12]. Therefore, it is important that
therapeutic intervention strategies targeting markers of chronic low-grade inflammation similarly
address dysregulated leukocyte signaling.
Dietary and lifestyle therapies that promote weight loss and improved diet quality have been shown
to effectively ameliorate markers of systemic inflammation, including inflammatory cytokines and
acute phase proteins such as C-reactive protein (CRP) and lipoprotein-associated serum amyloid A
(SAA) [13–15]. Moderate weight loss (~5% of body weight) has additionally been shown to reduce
inflammatory gene expression and nuclear factor κB (NF-κB) DNA binding activity in peripheral
blood mononuclear cells (PBMC) from obese women [9]. PBMC inflammation is also differentially
affected by consumption of diets rich in monounsaturated vs. saturated fats [16], and may be reduced
by intake of antioxidant-rich foods [17].
In addition to weight loss and dietary manipulation, the regulation of leukocyte cholesterol flux
has recently garnered significant attention due to its implications for inflammation, immunity,
atherosclerosis, and metabolic disease [18–20]. Leukocytes with elevated levels of cholesterol have
been shown to be more inflammatory and hyperproliferative [18,21,22], which may lead to
inappropriate inflammatory hyper-responsiveness to stimuli, impaired resolution of inflammation, or
misguided immune responses.
HDL-associated lipid transporters, including ATP-binding cassette transporter A1 (ABCA1) and
ATP-binding cassette G1 (ABCG1), have been shown to play significant roles in the modulation of
leukocyte cholesterol content. While the anti-atherogenic properties of both ABCA1 and ABCG1 have
been well documented due to their capacity to participate in the initiation of reverse cholesterol
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transport through efflux of macrophage foam cell lipids to HDL [23–25], these proteins additionally
possess the capacity to reduce inflammatory responsiveness through depletion of lymphocyte cholesterol
content and lipid raft formation [26,27]. Cellular cholesterol depletion impairs the formation of lipid rafts
within the plasma membrane where transmembrane proteins and receptors such as toll-like receptor 4
(TLR4) reside, thereby blunting the activation of inflammatory signaling [26–28]. ABCA1 expression in
leukocytes has additionally been implicated in cellular recruitment and migration, as deletion of
leukocyte-specific ABCA1 results in more advanced atherosclerotic lesions, as well as increased
leukocyte counts in the liver, spleen, and peripheral blood [29]. Further, ABCA1 is thought to efflux
LPS to HDL as a means of neutralizing its inflammatory effects, while also serving as a transport
system for excretion of LPS from the body via the bile [30–32].
With previous findings coming from animal and cell studies, we set out to determine whether the
dynamics between leukocyte inflammation and cholesterol flux could be altered by diet in human
subjects classified with MetS—individuals at increased risk for developing CVD and T2DM [33].
We have previously demonstrated that daily consumption of whole egg during moderate carbohydrate
restriction exerts favorable effects on inflammatory markers and HDL profiles in MetS. Intake of
whole eggs for 12 weeks reduced plasma tumor necrosis factor α (TNFα) and SAA [13], in addition to
altering HDL lipid composition and the ex vivo cholesterol-accepting capacity of subject serum from
cholesterol-loaded macrophages [34]. These benefits were not observed in subjects consuming egg
white-based, yolk-free egg substitute, suggesting that these effects are attributable to components
present in egg yolk. While egg whites contain a variety of bioactive proteins with anti-microbial,
anti-hypertensive, and antioxidant properties, egg yolks contain various anti-inflammatory factors,
including the antioxidant carotenoids lutein and zeaxanthin, and a wide range of bioactive
phospholipid species. [34–36]. Therefore, we sought to determine whether whole egg intake during
carbohydrate restriction could further modulate inflammatory properties of PBMCs in MetS, and
whether any observed changes correspond to alterations in cellular cholesterol content and distribution
in lipid rafts.
2. Experimental Section
2.1. Study Design and Dietary Intervention
Men (n = 12) and women (n = 25) classified with MetS according to the National Cholesterol
Education Program (NCEP): Adult Treatment Panel (ATP) III criteria [33] were recruited to
participate in a 12-week parallel, randomized, single-blind intervention study. Inclusion criteria for
participation included age of 30–70 years old and no history of chronic or metabolic disease.
All subjects were instructed to follow a moderate carbohydrate-restricted diet (25%–30% of energy
from carbohydrate, 25%–30% of energy from protein, 45%–50% of energy from fat) throughout the
12-week intervention, in addition to consuming either three whole eggs per day (EGG group, n = 20)
or the equivalent amount of egg white-based, yolk-free egg substitute (SUB group, n = 17).
Assignment to EGG and SUB groups was random, with subjects matched on the basis of age, gender,
and body mass index. Liquid whole egg (EGG group) and egg substitute (SUB group) products
(Sysco Corporation, Houston, TX, USA) were provided to subjects on a biweekly basis in coded
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containers. The daily serving of whole eggs provided 186 kcal, 0 g carbohydrate, 16 g protein, 12 g fat,
and 534 mg cholesterol, whereas the egg substitute provided 60 kcal, 2 g carbohydrate, 14 g protein,
0 g fat, and 0 mg cholesterol. Additional details of this intervention have been previously
described [13,34,35,37]. This study was approved by the Institutional Review Board at the University
of Connecticut (Protocol #: H10-173).
2.2. Blood Collection and Body Weight
Fasting blood samples were collected at baseline and week 12 of the intervention for isolation
of PBMCs and serum for cell culture assays. All samples were processed under sterile conditions.
Serum was aliquoted and stored at −80 °C. Body weight was measured biweekly from baseline to
week 12. As expected with moderate carbohydrate-restriction, average body weight loss in both groups
was ~4% with no difference between EGG and SUB groups [13].
2.3. Peripheral Blood Mononuclear Cell Isolation
Fasting blood (50 mL) was collected into EDTA vacutainer tubes for isolation of PBMCs at
baseline and week 12 of the intervention. Due to low blood recovery in four subjects, PBMCs were
collected from 34 EGG (n = 18) and SUB (n = 15) group participants. PBMCs were isolated by density
gradient centrifugation using Ficoll Paque PLUS (GE Healthcare, Pittsburgh, PA, USA) according to
the manufacturer’s instructions. Whole blood was diluted with sterile PBS, layered over Ficoll Paque
PLUS, and centrifuged at 400× g for 35 min using a Beckman Coulter centrifuge with a swing-bucket
rotor to separate the PBMC buffy coat. PBMC buffy coats were collected, washed twice with PBS,
and resuspended in RPMI. Aliquots of freshly isolated PBMCs were taken for collection of RNA,
nuclear extracts, and whole cell lysates as described below. Remaining cells were diluted 1:1 with
cryopreservation media (RPMI containing 20% fetal bovine serum, 10% dimethyl sulfoxide) and
frozen at a controlled rate in CoolCell containers (BioCision, LLC, Larkspur, CA, USA) at −80 °C for
at least 24 h. PBMC samples were then transferred to liquid nitrogen for long-term storage. PBMC
recovery from whole blood was not sufficient to conduct every experiment on samples from each
subject. Sample sizes for each measurement are reported below.
2.4. Quantitative Real-Time RT-PCR
PBMC mRNA expression of inflammatory genes was determined by quantitative real-time
RT-PCR (qRT-PCR) [38,39]. RNA was extracted from freshly isolated PBMCs using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. One µg of RNA
was treated with DNase I (Promega, Madison, WI, USA) and reverse transcribed by MMLV reverse
transcriptase (Promega, Madison, WI, USA) using a Bio-Rad C1000 Thermal Cycler (Bio-Rad, Hercules,
CA, USA). qRT-PCR analysis was performed using the Sybr Green procedure with a Bio-Rad CFX96
system (Bio-Rad, Hercules, CA, USA). Primer sequences were designed according to the GenBank
database, and are presented in Table 1. Expression of mRNA values was calculated using the threshold
cycle (Ct) value. Relative expression levels of each target gene were calculated using the comparative
2−ΔΔCt method following normalization to 18S rRNA expression [38–40].
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Table 1. Quantitative real-time RT-PCR primer sequences.

Gene

Forward Primer

Reverse Primer

ABCA1
ABCG1
HMGCR
IL-1β
IL-6
LDLR
TLR4
TNFα
18S RNA

5′-TTTCTCAGACAACACTTGACCAAGTA-3′
5′-CGGAGGGCAGCTGTGAAC-3′
5′-CCCAGTTGTGCGTCTTCCA-3′
5′-ACGATGCACCTGTACGATCACT-3′
5′-GCTGCAGGCACAGAACCA-3′
5′-ACTGGGTTGACTCCAAACTTCAC-3′
5′-GCAGGTGCTGGATTTATC-3′
5′-GGGACCTCTCTCTAATCA-3′
5′-CGGCTACCACATCCAAGGAA-3′

5′-GGTTTTTGTGTAATGAGAGGTCTTTTAA-3′
5′-GGGTCCTTCAGGAACCGAAT-3′
5′-TTCGAGCCAGGCTTTCACTT-3′
5′-CACCAAGCTTTTTTGCTGTGAGT-3′
5′-GCTGCGCAGAATGAGATGAG-3′
5′-GGTTGCCCCCGTTGACA-3′
5′-GTAGAGAGGTGGCTTAGG-3′
5′-CTACAACATGGGCTACAG-3′
5′-GCTGGAATTACCGCGGCT-3′

2.5. NF-κB p65 DNA Binding Activity
Nuclear fractions were collected from freshly isolated PBMCs using a Nuclear Extraction kit
(Active Motif, Carlsbad, CA, USA) following the manufacturer’s instructions [38,41]. Nuclear
fractions were stored at −80 °C until analysis. Total nuclear protein was determined by BCA assay
(Pierce, Rockford, IL, USA), then used to determine the DNA binding activity of the NF-B p65
subunit using the TransAM® NF-κB p65 Kit (Active Motif, Carlsbad, CA, USA) according to the
manufacturer’s instructions. Data are presented as the spectrophotometric reading at optical density
(OD) 450 nm.
2.6. PBMC Stimulation Assays
Inflammatory responses to LPS were assessed in a subset of subject PBMCs (EGG: n = 5; SUB: n = 5).
PBMCs were rapidly thawed in a 37 °C water bath, then quantified and assessed for viability using an
automated cell counter (Bio-Rad, Hercules, CA, USA) with trypan blue exclusion. Maintenance of
viability was further confirmed in cultured PBMCs. 2 × 106 viable cells/mL/well were plated in
12-well plates, then treated with or without lipopolysaccharide (LPS; 500 ng/mL) for 6 hours at 37 °C
in serum-free RPMI. Media was then collected and assayed for TNFα (BD Biosciences, San Jose,
CA, USA), IL-1β, and IL-10 (Abcam, Cambridge, MA, USA) by ELISA according to the
manufacturer’s instructions.
2.7. Quantification of PBMC Cholesterol Content
PBMC cholesterol content (EGG: n = 15; SUB: n = 13) was measured by gas chromatography/mass
spectrometry (GC/MS) using an Agilent 7890 GC/MS equipped with an Agilent HP-5MS capillary
column with dimensions: 30 m × 0.25 mm (0.25 μm film thickness). PBMC cholesterol was extracted
by isopropyl alcohol following the addition of 5α-cholestane as an internal standard. PBMC lipids
were dissolved in hexane prior to injection. Run conditions were: Initial temperature = 150 °C; Temp
ramp = 15 °C/min to 225 °C (hold for 5 min); Temp ramp = 15 °C/min to 300 °C (hold for 10 min);
with a total run time of 25 min. Helium was used as the carrier gas. Cholesterol values were
normalized to total cell protein as determined by BCA assay (Pierce, Rockford, IL, USA).
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2.8. Quantification of PBMC ABCA1 Protein
Whole cell lysates were collected from freshly isolated PBMCs (EGG: n = 11; SUB: n = 10) as
described by Rasmussen et al. [39]. Briefly, following isolation, PBMCs were pelleted and
resuspended in whole cell lysis buffer (150 mmol/L NaCl, 25 mmol/L Tris-HCL, pH 7.4, 1% Triton
X-100) containing Protease Inhibitor Cocktail set III (Calbiochem, Darmstadt, Germany) for 20 min
on ice. Cells were repelleted to collect the supernatant for storage at −80 °C until analysis. ABCA1
protein content was determined by ELISA (BIOTANG Inc., Waltham, MA, USA). Data are presented
as ng protein per 1 × 106 cells.
2.9. Lipid Raft Staining, Microscopy, and Quantification
Lipid rafts were quantified using the Vybrant Alexa Fluor 488 Lipid Raft Labeling Kit
(Molecular Probes, Eugene, OR, USA) according to the manufacturer’s instructions. Briefly,
cryopreserved PBMCs were rapidly thawed at 37 °C, quantified and assessed for viability. 1 × 106
viable cells were then labeled with a fluorescent cholera toxin subunit B (CT-B)-Alexa Fluor 488
conjugate, which binds to the pentasaccharide chain of plasma membrane ganglioside GM1 localized
within lipid raft domains. It has previously been shown that leukocyte lipids rafts are maintained
following freezing [42]. An anti-CT-B antibody was then added to induce crosslinking of the
fluorescent conjugate. PBMCs were loaded onto chamber slides to visualize lipid raft fluorescence
using a Leica TCS SP2 Laser Scanning Confocal microscope (Leica Microsystems Inc., Buffalo
Grove, IL, USA) and 40X oil objective. Total lipid raft fluorescence was quantified using a fluorescence
plate reader at excitation 488 and absorbance/emission 495/519, then normalized to cell protein as
determined by BCA assay (Pierce, Rockford, IL, USA).
2.10. Statistical Analysis
All statistical analyses were performed using SPSS version 18. Paired t tests were used to test
differences between baseline vs. week 12 values within EGG or SUB groups. Independent t tests were
used to compare the differences in absolute or percent change in variables between groups. Bivariate
Pearson correlations were used to determine relationships between parameters. Data are reported as
mean ±SEM unless noted otherwise. P < 0.05 was considered significant.
3. Results
3.1. Effects of Egg Intake during Moderate Carbohydrate Restriction on Inflammatory Gene Expression
We sought to determine whether our dietary intervention modulated inflammatory PBMC gene
expression. Interestingly, while we did not observe changes in IL-6 (Figure 1B), IL-1β (Figure 1C), or
TNFα (Figure 1D) mRNA expression in either group, TLR4 mRNA expression increased from
baseline to week 12 in the EGG group only (Figure 1A). No significant changes in PBMC NF-κB p65
DNA binding activity were observed in either group (data not shown).
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Figure 1. Whole egg intake during moderate carbohydrate restriction increases PBMC
mRNA expression of TLR4. PBMC mRNA expression of pro-inflammatory genes at
baseline and week 12 of a moderate carbohydrate-restricted diet plus whole egg (n = 18) or
egg substitute (n = 15) intake. qRT-PCR was used to measure PBMC mRNA expression of
(A) TLR4; (B) TNFα; (C) IL-1β; and (D) IL-6. All data were normalized to 18S rRNA
expression and expressed as mean ± SEM. * P = 0.011, paired t test comparing PBMC
TLR4 mRNA expression between baseline and week 12 in the EGG group.

A

B
P = 0.2

1.5

1.0

0.5

0.0

C
15
Relative mRNA expression

*

P = 0.011

Week 0 Week 12

Week 0 Week 12

EGG

SUB

TNFa
P = 0.8

6
P = 0.6
4

2

0

D

Week 0 Week 12

Week 0 Week 12

EGG

SUB

4

IL-1b
P = 0.8

10

P = 0.8

5

0

Relative mRNA expression

2.0

8

TLR4

Week 0 Week 12

Week 0 Week 12

EGG

SUB

Relative mRNA expression

Relative mRNA expression

2.5

3

IL-6
P = 0.2
P = 0.5

2

1

0

Week 0 Week 12

Week 0 Week 12

EGG

SUB

3.2. Inflammatory Challenge
We further assessed the inflammatory potential of PBMCs following egg intake during moderate
carbohydrate restriction by measuring TNFα, IL-1β, and IL-10 secretion in response to LPS stimuli.
Under basal, non-stimulated conditions, no significant changes in PBMC TNFα (Figure 2A) or IL-1β
(Figure 2B) production from baseline to week 12 were observed in either group. Conversely, LPS-induced
PBMC production of TNF and IL-1β were increased from baseline to week 12 in the SUB group,
whereas no changes in TNFα or IL-1β were observed in the EGG group (Figure 2A,B). No significant
differences in IL-10 levels were observed under LPS or non-stimulated conditions (data not shown).
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Figure 2. Egg substitute intake during carbohydrate restriction increases PBMC
inflammatory responsiveness to LPS. Whole egg (n = 5) and egg substitute (n = 5) intake
during carbohydrate restriction differentially affected LPS-induced PBMC cytokine
secretion. (A) ELISA analysis for PBMC TNFα and (B) IL-1β secretion with or without
stimulation with LPS for 6 h at baseline and week 12 of the dietary intervention. Data are
represented as mean ±SEM. * P < 0.05, ** P < 0.01; paired t test comparing the difference
between baseline vs. week 12 in SUB group.
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3.3. Cholesterol Gene Expression
We further aimed to identify whether this change corresponded to alterations in the expression of
genes related to cholesterol efflux (ABCA1 and ABCG1), synthesis (HMGCR), and uptake (LDLR).
Interestingly, ABCA1 mRNA expression significantly increased from baseline to week 12 in the EGG
group only (Figure 3A). We similarly observed a trend toward an increase in ABCA1 protein in the
EGG group from baseline to week 12 (P = 0.07; data not shown), as well as a strong trend toward
greater percent change in ABCA1 protein from baseline in the EGG group (+5.5% ± 9.4%) when
compared to the SUB group (−1.9% ± 7.1%) (Figure 3E). EGG group-specific increases in HMGCR
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mRNA expression were also observed from baseline to week 12 (Figure 3C), whereas no changes in
ABCG1 (Figure 3B) or LDLR mRNA expression were observed in either group (Figure 3D).
Figure 3. Egg intake during carbohydrate restriction alters PBMC cholesterol gene
expression. PBMC expression of cholesterol genes at baseline and week 12 of a moderate
carbohydrate-restricted diet plus whole egg (n = 18) or egg substitute (n = 15) intake.
qRT-PCR was used to measure PBMC mRNA expression of (A) ABCA1; (B) ABCG1;
(C) HMGCR; and (D) LDLR. qRT-PCR data were normalized to 18S rRNA expression.
Differences between baseline and week 12 determined by paired t test; (E) ABCA1 protein
was quantified in whole cell lysates collected from freshly isolated PBMCs (EGG: n = 11;
SUB: n = 10) at baseline and week 12 of the intervention. Data are represented as %
change in ABCA1 (ng/1 × 106 cells) from baseline to week 12. * P < 0.05; paired t test
comparing the difference between baseline vs. week 12 in EGG group. # P = 0.057;
independent t test comparing the difference in % change in ABCA1 protein expression
between EGG and SUB groups.
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3.4. Effects of Egg Intake on PBMC Cholesterol and Lipid Raft Content
Total PBMC cholesterol content was measured to determine whether egg consumption altered
leukocyte cholesterol levels. There was a strong trend towards a decrease in PBMC cholesterol content
from baseline to week 12 in the EGG group (P = 0.057), whereas no changes in cellular cholesterol
levels were observed in the SUB group (Figure 4A). No difference in baseline PBMC cholesterol
content was observed between groups (P = 0.14; data not shown). We further sought to determine
whether our intervention altered the cellular distribution of cholesterol and lipid raft formation. Lipid
rafts were labeled with the Vybrant Alexa Fluor 488 Lipid Raft Labeling Kit and visualized using a
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Leica TCS SP2 Laser Scanning Confocal microscope (Figure 4B). Total lipid raft fluorescence was
quantified using a fluorescence plate reader, and revealed no changes in lipid raft formation from
baseline to week 12 in either EGG or SUB group (data not shown). However, we found that changes in
PBMC total cholesterol positively correlated with percent changes in lipid raft content (Figure 4C).
Figure 4. Effects of egg intake and carbohydrate restriction on PBMC cholesterol and lipid
raft content. (A) PBMC cholesterol was measured by GC/MS and normalized to cell
protein. Values are presented as mean ± SEM. # P = 0.057 for paired t test between
baseline and week 12 in the EGG group. EGG: n = 15; SUB: n = 13; (B) PBMC lipid rafts
were labeled with the Vybrant Alexa Fluor 488 Lipid Raft Labeling Kit (Molecular Probes,
Eugene, OR, USA) and visualized using a Leica TCS SP2 Laser Scanning Confocal
microscope (Leica Microsystems Inc., Buffalo Grove, IL, USA), 40× oil objective;
(C) Relationship between percent changes in total lipid raft fluorescence (quantified by
fluorescence plate reader) and PBMC cholesterol content as determined by Pearson
correlation.

4. Discussion
Elevated levels of basal leukocyte inflammation have been demonstrated in obesity and metabolic
syndrome [9,10,43], and have been implicated in leukocyte-driven progression of metabolic disease [6,7].
HDL-leukocyte interactions via ABCA1 further modify cellular cholesterol flux and inflammatory
potential; therefore, dietary strategies that alter HDL-leukocyte dynamics may have profound
effects on obesity-related disease progression. Since we have previously demonstrated that bioactive
nutrient-rich egg yolk improves plasma inflammatory markers and HDL profiles in metabolic
syndrome (MetS) under carbohydrate restriction, we further sought to determine whether egg yolk
intake affects peripheral blood mononuclear cell (PBMC) inflammation and cholesterol homeostasis in
MetS. Interestingly, whole egg intake during carbohydrate restriction did not alter inflammatory
PBMC responsiveness to LPS, whereas LPS-induced PBMC TNFα and IL-1β secretion was increased
by moderate carbohydrate restriction and egg substitute intake. These differences were observed
despite increases in PBMC TLR4 mRNA expression in the whole egg group. We additionally detected
significant increases in PBMC ABCA1 and HMGCR mRNA expression from whole egg intake only,
in addition to a trend toward greater increases ABCA1 protein. Further, we observed a positive
correlation between changes in PBMC cholesterol and lipid raft content. Together, these findings
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suggest that PBMC inflammation and cholesterol homeostasis can be modulated by egg intake and
moderate carbohydrate restriction in MetS.
Previous studies have reported reductions in inflammatory gene expression in PBMCs following
moderate weight loss [9]. This phenomenon is thought to be indicative of global improvements in
metabolic tissue stress and function, thereby reducing the presence of pathogenic factors capable of
activating leukocytes, while also promoting the resolution of inflammatory responses [1,7,9].
However, despite moderate weight loss and decreases in plasma TNFα and SAA from whole egg
consumption in this population [13], we did not observe reductions in PBMC mRNA expression of
TNFα, IL-1β, or IL-6 from baseline to week 12. Conversely, whole egg intake increased PBMC
mRNA expression of TLR4—a member of the TLR family of pattern recognition receptors that
recognizes exogenous and endogenous ligands, including Gram-negative bacteria-derived LPS and
fatty acids [44]. Although the subjects in this study reduced body weight by an average of ~4% [13],
it is possible that changes in body weight were not significant enough to alter inflammatory gene
expression in PBMCs. It is also possible that the moderate carbohydrate-restricted diet, which
provided 45%–50% of energy from fat [13], blunted any changes in inflammatory gene expression
associated with weight loss. High-fat diets have been associated with increased PBMC mRNA
expression of IL-8 [45], higher nuclear NF-κB p65 protein levels [16], and greater TLR4 expression in
a variety of tissues, including the intestine [46] and adipose tissue [47]. While dietary fat intake did not
differ between EGG and SUB groups as previously reported [13], it is possible that the fatty acids
provided by whole eggs were more bioavailable due to the abundance of yolk phospholipids [34,48,49],
which may have contributed to the EGG group-specific increases in TLR4 mRNA expression in PBMCs.
Despite observed changes in TLR4 gene expression, our study is limited in that only mRNA levels
of TLR4 were measured due to a lack of available sample to assess protein levels. While various
inflammatory factors differentially regulate TLR4 mRNA expression, functional activity of this
receptor is further regulated at the level of protein translation, cell surface localization, accessory
molecule availability and expression, and plasma membrane composition [50]. Interestingly, omega-3
fatty acids have been shown to inhibit LPS- or saturated fatty acid-induced TLR4 activation by altering
plasma membrane lipid raft composition, thereby preventing the assembly of TLR4 homodimers and
signaling component complexes that is critical for inflammatory signal transduction [51]. Similar
impairments in TLR4 signaling have been demonstrated via depletion of cellular cholesterol—an
important structural component of lipid rafts [22,27]. Therefore, simply observing changes in TLR4
mRNA expression does not necessarily signify changes in cellular inflammatory potential.
Accordingly, daily whole egg intake for 12 weeks rendered PBMCs less responsive to LPS-induced
cytokine secretion when compared to responses from egg substitute consumption during carbohydrate
restriction. These findings suggest that (1) carbohydrate restriction (in conjunction with egg substitute
intake) induced greater inflammatory responses upon PBMC stimulation with LPS; and (2) a
component of the egg yolk blunted increased PBMC responsiveness to LPS induced by carbohydrate
restriction. Egg yolks contain various anti-inflammatory factors, including the antioxidant carotenoids
lutein and zeaxanthin, and numerous bioactive phospholipid species [34–36]. Additionally, given the
changes in HDL composition and the increased cholesterol-accepting capacity of serum from egg
intake described in previous studies [34,52], we hypothesized that the differences in PBMC
inflammatory potential between the EGG and SUB groups could be due to changes in cellular
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cholesterol content, lipid raft formation, and ABCA1 expression. TLR4 signaling is dependent upon
plasma membrane composition and lipid raft integrity to facilitate the convergence of LPS receptor
complex components required for LPS/TLR4-mediated inflammatory signaling [50,53]. The inflammatory
potential of leukocytes is further regulated through modulation of the HDL-associated lipid transporter
ABCA1, where greater expression of these membrane transporters is known to deplete lipid raft
cholesterol and suppress TLR4-mediated inflammatory signaling [22,27]. Therefore, it is possible that
the effects of egg intake during carbohydrate restriction on PBMC inflammatory potential may be
attributable to alterations in HDL-leukocyte dynamics.
Correspondingly, we observed that egg consumption trended toward decreasing PBMC cholesterol
content after 12 weeks with concomitant increases in ABCA1 expression. In addition to EGG
group-specific increases in ABCA1 mRNA expression, we additionally observed increased PBMC
mRNA expression of HMGCR in the EGG group only, whereas no changes in ABCG1 or LDLR were
observed in either EGG or SUB group. While the change in PBMC cholesterol content in the EGG
group did not reach significance (P = 0.057), slight shifts in cellular content or compartmentalization
may explain the observed increase in HMGCR mRNA expression, traditionally driven by sterol
regulatory element binding protein-2 (SREBP2)-mediated activation in response to reduced cellular
cholesterol levels [54].
Increased ABCA1 mRNA expression observed in this study may be due to the improved metabolic
and inflammatory milieu from egg intake during moderate carbohydrate restriction. ABCA1
expression is reduced in patients with obesity-related metabolic diseases such as hypertension and
T2DM [55,56], mouse models of insulin resistance and diabetes [57], and by pro-inflammatory
mediators such as TNFα and CRP [58,59]. We have previously demonstrated that whole egg intake
during moderate carbohydrate restriction reduces TNFα and SAA in this same MetS population [13],
whereas no changes were observed in the group consuming egg substitute. Further, insulin resistance
(HOMA-IR) was reduced to a greater extent in subjects consuming whole eggs [37]. Together, these
findings suggest that whole egg intake during moderate carbohydrate restriction promotes global
metabolic improvements that favors ABCA1 expression.
ABCA1 has repeatedly been shown to serve as a link between cellular cholesterol flux and
inflammatory potential. Landry et al. [60] demonstrated that ABCA1 expression leads to significant
redistribution of cholesterol and sphingomyelin from lipid rafts to non-raft regions of cell membranes
through its ATPase-related and efflux functions [60]. Cholesterol serves as an essential structural
component of lipid rafts, which are dynamic cholesterol-rich microdomains within the exoplasmic
leaflets of the phospholipid bilayer of plasma membranes where transmembrane proteins and
receptors reside—including pattern recognition receptors such as TLR4 [28]. Elevated levels of cellular
cholesterol favor the formation of lipid rafts, and have been associated with increased pro-inflammatory
responses in macrophages and T lymphocytes due to lowered cellular activation thresholds [18,21,22].
ABCA1-mediated reductions in lipid raft content have been shown to increase ADAM17-mediated
cleavage of TNF and TNF receptors, which may result in reduced TNFα signaling [61]. Lipid raft
structure also affects TLR signaling, as TLR4 and MyD88/TRIF-mediated inflammatory gene
expression was significantly increased in peritoneal macrophages isolated from ABCA1−/−, ABCG1−/−,
and ABCA1−/−ABCG1−/− mice [19]. ApoA-I-ABCA1 interactions have also been shown to trigger
JAK2-mediated activation of STAT3, which can suppress LPS-induced pro-inflammatory gene
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expression of TNFα and IL-6 in macrophages [62,63]. Interestingly, changes in PBMC cholesterol
levels between baseline and week 12 positively correlated with percent changes in PBMC lipid raft
content. This is the first study to our knowledge that has investigated the effects of diet on leukocyte
lipid rafts within the context of human intervention trials. Together, these findings further support our
observations that egg intake concomitantly increases ABCA1 expression while blunting the increases
in LPS-induced cytokine secretion from carbohydrate restriction.
5. Conclusions
We have demonstrated that whole egg intake during moderate carbohydrate restriction alters
PBMC inflammation and cholesterol homeostasis. The data presented in this study highlight a novel
perspective on the anti-inflammatory and lipid-modulating properties of this dietary intervention.
Given the significant role of leukocytes in immunity and chronic disease, regulation of cellular
cholesterol flux and lipid raft formation may have important implications for the physiological
consequences of obesity. Therefore, our findings support the need for future studies to determine the
clinical consequences of our observations in relation to metabolic disease progression and immunity.
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